Reviewe ||| S:0 E:7 ||| NNP
:  ||| S:7 E:9 ||| :
Genetics  ||| S:9 E:18 ||| NNP
and  ||| S:18 E:22 ||| CC
genomics  ||| S:22 E:31 ||| NN
in  ||| S:31 E:34 ||| IN
equine  ||| S:34 E:41 ||| JJ
exercise  ||| S:41 E:50 ||| NN
physiology ||| S:50 E:60 ||| NNS
:  ||| S:60 E:62 ||| :
an  ||| S:62 E:65 ||| DT
overview  ||| S:65 E:74 ||| NN
of  ||| S:74 E:77 ||| IN
the  ||| S:77 E:81 ||| DT
new  ||| S:81 E:85 ||| JJ
applications  ||| S:85 E:98 ||| NNS
of  ||| S:98 E:101 ||| IN
molecular  ||| S:101 E:111 ||| JJ
biology  ||| S:111 E:119 ||| NN
as  ||| S:119 E:122 ||| IN
positive  ||| S:122 E:131 ||| JJ
and  ||| S:131 E:135 ||| CC
negative  ||| S:135 E:144 ||| JJ
markers  ||| S:144 E:152 ||| NN
of  ||| S:152 E:155 ||| IN
performance  ||| S:155 E:167 ||| NN
and  ||| S:167 E:171 ||| CC
health  ||| S:171 E:178 ||| NN
Equine  ||| S:178 E:185 ||| NNS
breeding  ||| S:185 E:194 ||| VBG
selection  ||| S:194 E:204 ||| NN
has  ||| S:204 E:208 ||| VBZ
been  ||| S:208 E:213 ||| VBN
developed  ||| S:213 E:223 ||| VBN
by  ||| S:223 E:226 ||| IN
applying  ||| S:226 E:235 ||| VBG
quantitative  ||| S:235 E:248 ||| JJ
genetic  ||| S:248 E:256 ||| JJ
methods  ||| S:256 E:264 ||| NNS
for  ||| S:264 E:268 ||| IN
calculating  ||| S:268 E:280 ||| VBG
the  ||| S:280 E:284 ||| DT
heritability  ||| S:284 E:297 ||| NN
of  ||| S:297 E:300 ||| IN
the  ||| S:300 E:304 ||| DT
complex  ||| S:304 E:312 ||| JJ
traits  ||| S:312 E:319 ||| JJ
such  ||| S:319 E:324 ||| JJ
as  ||| S:324 E:327 ||| IN
performance  ||| S:327 E:339 ||| NN
in  ||| S:339 E:342 ||| IN
racing  ||| S:342 E:349 ||| VBG
or  ||| S:349 E:352 ||| CC
sport  ||| S:352 E:358 ||| NN
competitions ||| S:358 E:370 ||| NNS
.  ||| S:370 E:372 ||| .
With  ||| S:372 E:377 ||| IN
the  ||| S:377 E:381 ||| DT
great  ||| S:381 E:387 ||| JJ
development  ||| S:387 E:399 ||| NN
of  ||| S:399 E:402 ||| IN
biotechnologies ||| S:402 E:417 ||| NN
,  ||| S:417 E:419 ||| ,
equine  ||| S:419 E:426 ||| JJ
molecular  ||| S:426 E:436 ||| JJ
genetics  ||| S:436 E:445 ||| NN
has  ||| S:445 E:449 ||| VBZ
come  ||| S:449 E:454 ||| VBN
of  ||| S:454 E:457 ||| IN
age ||| S:457 E:460 ||| NN
.  ||| S:460 E:462 ||| .
The  ||| S:462 E:466 ||| DT
recent  ||| S:466 E:473 ||| JJ
sequencing  ||| S:473 E:484 ||| NN
of  ||| S:484 E:487 ||| IN
the  ||| S:487 E:491 ||| DT
equine  ||| S:491 E:498 ||| JJ
genome  ||| S:498 E:505 ||| NN
by  ||| S:505 E:508 ||| IN
an  ||| S:508 E:511 ||| DT
international  ||| S:511 E:525 ||| JJ
consortium  ||| S:525 E:536 ||| NN
was  ||| S:536 E:540 ||| VBD
a  ||| S:540 E:542 ||| DT
major  ||| S:542 E:548 ||| JJ
advance  ||| S:548 E:556 ||| NN
that  ||| S:556 E:561 ||| WDT
will  ||| S:561 E:566 ||| MD
impact  ||| S:566 E:573 ||| VB
equine  ||| S:573 E:580 ||| JJ
genomics  ||| S:580 E:589 ||| NN
in  ||| S:589 E:592 ||| IN
the  ||| S:592 E:596 ||| DT
near  ||| S:596 E:601 ||| JJ
future ||| S:601 E:607 ||| NN
.  ||| S:607 E:609 ||| .
With  ||| S:609 E:614 ||| IN
the  ||| S:614 E:618 ||| DT
rapid  ||| S:618 E:624 ||| JJ
progress  ||| S:624 E:633 ||| NN
in  ||| S:633 E:636 ||| IN
equine  ||| S:636 E:643 ||| JJ
genetics ||| S:643 E:651 ||| NN
,  ||| S:651 E:653 ||| ,
new  ||| S:653 E:657 ||| JJ
applications  ||| S:657 E:670 ||| NNS
in  ||| S:670 E:673 ||| IN
early  ||| S:673 E:679 ||| JJ
performance  ||| S:679 E:691 ||| NN
evaluation  ||| S:691 E:702 ||| NN
and  ||| S:702 E:706 ||| CC
the  ||| S:706 E:710 ||| DT
detection  ||| S:710 E:720 ||| NN
of  ||| S:720 E:723 ||| IN
disease  ||| S:723 E:731 ||| NN
markers  ||| S:731 E:739 ||| NNS
become  ||| S:739 E:746 ||| VBP
available ||| S:746 E:755 ||| JJ
.  ||| S:755 E:757 ||| .
Many  ||| S:757 E:762 ||| JJ
new  ||| S:762 E:766 ||| JJ
biomolecular  ||| S:766 E:779 ||| JJ
tools  ||| S:779 E:785 ||| NNS
will  ||| S:785 E:790 ||| MD
change  ||| S:790 E:797 ||| VB
management  ||| S:797 E:808 ||| NN
of  ||| S:808 E:811 ||| IN
horse  ||| S:811 E:817 ||| NN
selection ||| S:817 E:826 ||| NN
,  ||| S:826 E:828 ||| ,
disease  ||| S:828 E:836 ||| NN
diagnosis  ||| S:836 E:846 ||| NN
and  ||| S:846 E:850 ||| CC
treatment ||| S:850 E:859 ||| NN
.  ||| S:859 E:861 ||| .
The  ||| S:861 E:865 ||| DT
purpose  ||| S:865 E:873 ||| NN
of  ||| S:873 E:876 ||| IN
this  ||| S:876 E:881 ||| DT
review  ||| S:881 E:888 ||| NN
is  ||| S:888 E:891 ||| VBZ
to  ||| S:891 E:894 ||| TO
present  ||| S:894 E:902 ||| VB
new  ||| S:902 E:906 ||| JJ
developments  ||| S:906 E:919 ||| NNS
in  ||| S:919 E:922 ||| IN
equine  ||| S:922 E:929 ||| JJ
genetics  ||| S:929 E:938 ||| NN
and  ||| S:938 E:942 ||| CC
genomics  ||| S:942 E:951 ||| NN
for  ||| S:951 E:955 ||| IN
performance  ||| S:955 E:967 ||| NN
evaluation  ||| S:967 E:978 ||| NN
and  ||| S:978 E:982 ||| CC
health  ||| S:982 E:989 ||| NN
markers  ||| S:989 E:997 ||| NN
after  ||| S:997 E:1003 ||| IN
a  ||| S:1003 E:1005 ||| DT
short  ||| S:1005 E:1011 ||| JJ
summary  ||| S:1011 E:1019 ||| NN
of  ||| S:1019 E:1022 ||| IN
the  ||| S:1022 E:1026 ||| DT
previous  ||| S:1026 E:1035 ||| JJ
knowledge  ||| S:1035 E:1045 ||| NN
about  ||| S:1045 E:1051 ||| IN
the  ||| S:1051 E:1055 ||| DT
genetic  ||| S:1055 E:1063 ||| JJ
components  ||| S:1063 E:1074 ||| NNS
of  ||| S:1074 E:1077 ||| IN
the  ||| S:1077 E:1081 ||| DT
exercise  ||| S:1081 E:1090 ||| NN
performance  ||| S:1090 E:1102 ||| NN
traits ||| S:1102 E:1108 ||| NNS
.  ||| S:1108 E:1110 ||| .
